PITX2 gain-of-function in Rieger syndrome eye model.
The human autosomal-dominant disorder Axenfeld-Rieger syndrome presents with defects in development of the eyes, teeth, and umbilicus. The eye manifests with iris ruptures, irido-corneal adhesions, cloudy corneas, and glaucoma. Transcription factors such as PITX2 and FOXC1 have been found to carry point mutations, causing the disorder. However, for approximately 40% of the cases, the pathogenesis is unknown. It has been reported that some mutations in PITX2 increase transactivation, whereas most mutations cause defects in DNA binding or transactivation. It is not known whether up-regulation of PITX2 activity can cause the disorder as well. Here we test this hypothesis directly by overexpressing PITX2A as a transgene in mouse corneal mesenchyme and iris, using keratocan-flanking sequences. The mice presented with corneal opacification, corneal hypertrophy, irido-corneal adhesions, and severely degenerated retina, resembling glaucoma. The corneal hypertrophy also resembles the corneal hypertrophy of Pitx2-/- mice. Control transgenic mice carrying point mutations T68P or K88E in PITX2A were normal. These findings indicate a novel pathogenetic mechanism in which excess corneal and iridal PITX2A cause glaucoma and anterior defects that closely resemble Axenfeld-Rieger syndrome.
Holmberg
Johan
J
Lund University, Department of Cell and Molecular Biology, Section for Cell and Developmental Biology, BMC B12, Tornavägen 10, SE-22184 Lund, Sweden.
Liu
Chia-Yang
CY
Hjalt
Tord A
TA
D000483:Alleles; D000818:Animals; D015139:Blotting, Southern; D002874:Chromosome Mapping; D003094:Collagen / Q000737:chemistry; D003315:Cornea / Q000473:pathology; D004247:DNA / Q000378:metabolism; D004195:Disease Models, Animal; D005124:Eye Abnormalities / Q000235:genetics; D005128:Eye Diseases / Q000473:pathology; D005838:Genotype; D005901:Glaucoma / Q000473:pathology; D018398:Homeodomain Proteins / Q000235:genetics* / Q000502:physiology*; D006984:Hypertrophy; D007150:Immunohistochemistry; D020287:In Situ Nick-End Labeling; D007498:Iris / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D046529:Microscopy, Electron, Transmission; D008856:Microscopy, Fluorescence; D008954:Models, Biological; D008957:Models, Genetic; D017354:Point Mutation; D012160:Retina / Q000378:metabolism / Q000473:pathology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013577:Syndrome; D014157:Transcription Factors / Q000235:genetics* / Q000502:physiology*; D015533:Transcriptional Activation; D019076:Transgenes; D015854:Up-Regulation; D000097577:Homeobox Protein PITX2
D003094:Collagen; D004247:DNA; D018398:Homeodomain Proteins; D014157:Transcription Factors; D000097577:Homeobox Protein PITX2